233 related articles for article (PubMed ID: 23929656)
1. Identification of immunoreactive proteins of Streptococcus agalactiae isolated from cultured tilapia in China.
Liu G; Zhang W; Lu C
Pathog Dis; 2013 Dec; 69(3):223-31. PubMed ID: 23929656
[TBL] [Abstract][Full Text] [Related]
2. Identification of a virulence-related surface protein XF in piscine Streptococcus agalactiae by pre-absorbed immunoproteomics.
Liu G; Zhang W; Liu Y; Yao H; Lu C; Xu P
BMC Vet Res; 2014 Oct; 10():259. PubMed ID: 25344337
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteome analysis of two Streptococcus agalactiae strains from cultured tilapia with different virulence.
Li W; Su YL; Mai YZ; Li YW; Mo ZQ; Li AX
Vet Microbiol; 2014 May; 170(1-2):135-43. PubMed ID: 24594355
[TBL] [Abstract][Full Text] [Related]
4. Complete genome sequence of Streptococcus agalactiae GD201008-001, isolated in China from tilapia with meningoencephalitis.
Liu G; Zhang W; Lu C
J Bacteriol; 2012 Dec; 194(23):6653. PubMed ID: 23144401
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomics analysis of Streptococcus agalactiae reveals that isolates from cultured tilapia in China are closely related to the human strain A909.
Liu G; Zhang W; Lu C
BMC Genomics; 2013 Nov; 14():775. PubMed ID: 24215651
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus agalactiae, an emerging pathogen for cultured ya-fish, Schizothorax prenanti, in China.
Geng Y; Wang KY; Huang XL; Chen DF; Li CW; Ren SY; Liao YT; Zhou ZY; Liu QF; Du ZJ; Lai WM
Transbound Emerg Dis; 2012 Aug; 59(4):369-75. PubMed ID: 22146014
[TBL] [Abstract][Full Text] [Related]
7. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
[TBL] [Abstract][Full Text] [Related]
8. Microevolution of Streptococcus agalactiae ST-261 from Australia Indicates Dissemination via Imported Tilapia and Ongoing Adaptation to Marine Hosts or Environment.
Kawasaki M; Delamare-Deboutteville J; Bowater RO; Walker MJ; Beatson S; Ben Zakour NL; Barnes AC
Appl Environ Microbiol; 2018 Aug; 84(16):. PubMed ID: 29915111
[No Abstract] [Full Text] [Related]
9. GroEL, a novel vaccine candidate of piscine Streptococcus agalactiae identified by immunoproteome.
Li W; Li Y; Hu YZ; Mo XB; Xu GH; Xie LW; Li AX
Fish Shellfish Immunol; 2019 Jan; 84():377-383. PubMed ID: 30308296
[TBL] [Abstract][Full Text] [Related]
10. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.
Wang YT; Huang HY; Tsai MA; Wang PC; Jiang BH; Chen SC
Fish Shellfish Immunol; 2014 Dec; 41(2):250-9. PubMed ID: 25218275
[TBL] [Abstract][Full Text] [Related]
11. Genotyping of Streptococcus agalactiae strains isolated from fish, human and cattle and their virulence potential in Nile tilapia.
Pereira UP; Mian GF; Oliveira IC; Benchetrit LC; Costa GM; Figueiredo HC
Vet Microbiol; 2010 Jan; 140(1-2):186-92. PubMed ID: 19726142
[TBL] [Abstract][Full Text] [Related]
12. Aspects of the natural history and virulence of S. agalactiae infection in Nile tilapia.
Mian GF; Godoy DT; Leal CA; Yuhara TY; Costa GM; Figueiredo HC
Vet Microbiol; 2009 Apr; 136(1-2):180-3. PubMed ID: 19042097
[TBL] [Abstract][Full Text] [Related]
13. The pathogenic and antimicrobial characteristics of an emerging Streptococcus agalactiae serotype IX in Tilapia.
Zhang Z; Lan J; Li Y; Hu M; Yu A; Zhang J; Wei S
Microb Pathog; 2018 Sep; 122():39-45. PubMed ID: 29859291
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
Evans JJ; Klesius PH; Shoemaker CA
Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
Ma YP; Ke H; Liang ZL; Ma JY; Hao L; Liu ZX
Fish Shellfish Immunol; 2017 Jul; 66():345-353. PubMed ID: 28476676
[TBL] [Abstract][Full Text] [Related]
16. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.
Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X
Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276
[TBL] [Abstract][Full Text] [Related]
17. Inapparent Streptococcus agalactiae infection in adult/commercial tilapia.
Sun J; Fang W; Ke B; He D; Liang Y; Ning D; Tan H; Peng H; Wang Y; Ma Y; Ke C; Deng X
Sci Rep; 2016 May; 6():26319. PubMed ID: 27215811
[TBL] [Abstract][Full Text] [Related]
18. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
Nur-Nazifah M; Sabri MY; Siti-Zahrah A
Fish Shellfish Immunol; 2014 Mar; 37(1):193-200. PubMed ID: 24486904
[TBL] [Abstract][Full Text] [Related]
19. Genome reanalysis to decipher resistome, virulome, and attenuated characters of attenuated Streptococcus agalactiae strain HZAUSC001.
Zhang Z; Li Y; Hu M; Yu A
Microb Pathog; 2020 Oct; 147():104416. PubMed ID: 32745666
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the 10 kb sequence of piscine Streptococcus agalactiae on bacterial virulence].
Liu G; Zhu J; Shi Z; Ding M; Wang R; Yao H; Lu C; Xu P
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):110-9. PubMed ID: 27305785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
